Clinical Trials

448 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07604766 2026-06-02

RAINFOL-02

82 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07214779 2026-06-01

MAESTRA 2

466 enrolled

Ovarian Neoplasms

NCT06459180 2026-05-27

TroFuse-020

686 enrolled

Uterine Cervical Neoplasms

NCT07099898 2026-05-27

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)

420 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07213804 2026-05-27

FRAmework-01

1,080 enrolled

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms

NCT07286266 2026-05-27

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

450 enrolled

Ovarian Neoplasms

NCT06612151 2026-05-26

A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer

438 enrolled

Small Cell Lung Carcinoma

NCT06616532 2026-05-22

PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer

404 enrolled

SCLC

NCT06801834 2026-05-20

EVOKE-SCLC-04

695 enrolled

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT05153239 2026-05-13

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

705 enrolled

Small Cell Lung Carcinoma

NCT07545460 2026-04-22

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

404 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06828354 2026-04-20

A Study of SHR-A1811 in Subjects With Ovarian Cancer

300 enrolled

Ovarian Neoplasms

NCT06994195 2026-04-20

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)

384 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06500026 2026-04-17

A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)

722 enrolled

Small Cell Lung Carcinoma

NCT07418749 2026-04-06

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

398 enrolled

Uterine Cervical Neoplasms

NCT04697628 2026-02-24

innovaTV 301

502 enrolled 18 charts 1 FDA

Uterine Cervical Neoplasms

NCT07365241 2026-01-26

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

531 enrolled

Neoplasms, Small Cell Lung Carcinoma

NCT07218809 2026-01-16

TREVI-OC-01

1,100 enrolled

Carcinoma, Ovarian Epithelial

NCT05740566 2026-01-05

DeLLphi-304

509 enrolled 11 charts 1 FDA

Small Cell Lung Carcinoma

NCT07189455 2026-01-05

Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer

420 enrolled

Small Cell Lung Carcinoma

NCT06855069 2025-12-17

HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

468 enrolled

Ovarian Neoplasms

NCT04908787 2025-09-11

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

421 enrolled

Ovarian Neoplasms

NCT05092360 2025-08-28

ARTISTRY-7

Phase 3 Terminated

456 enrolled 19 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04209855 2025-08-27

MIRASOL

453 enrolled 18 charts 1 FDA

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT06954246 2025-06-18

A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

450 enrolled

Small Cell Lung Carcinoma

NCT03088813 2025-02-19

RESILIENT

491 enrolled 24 charts

Small Cell Lung Carcinoma

NCT06751485 2024-12-31

JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer

430 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06496048 2024-12-12

Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC

180 enrolled

Small Cell Lung Carcinoma

NCT06498479 2024-10-16

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

460 enrolled

Small Cell Lung Carcinoma

NCT06581380 2024-09-03

JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer

394 enrolled

Small Cell Lung Carcinoma

NCT06394492 2024-08-09

SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

440 enrolled

Ovarian Neoplasms

NCT06128837 2024-03-15

Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer

686 enrolled

Small Cell Lung Carcinoma

NCT02584478 2023-11-08

AL3818

Phase 3 Unknown

294 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT02481830 2023-07-27

CheckMate331

569 enrolled 13 charts

Lung Neoplasms

NCT04943627 2022-10-05

Balstilimab Versus Investigator Choice Chemotherapy in Patients With Recurrent Cervical Cancer (BRAVA)

Phase 3 Withdrawn

Uterine Cervical Neoplasms

NCT00976911 2022-06-21

AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer

361 enrolled 15 charts

Ovarian Neoplasms

NCT02566993 2021-10-28

ATLANTIS

613 enrolled 46 charts

Small Cell Lung Carcinoma

NCT03061812 2021-02-23

TAHOE

444 enrolled 16 charts

Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT02631876 2020-10-14

FORWARD I

366 enrolled 20 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02421588 2020-04-03

CORAIL

442 enrolled 33 charts

Ovarian Neoplasms

NCT00477282 2020-03-12

Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer

509 enrolled

Neoplasms, Ovarian Neoplasms

NCT00547651 2019-11-06

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

637 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT04073550 2019-08-29

Study of Anlotinib Hydrochloride Capsule in Subjects With Small Cell Lung Cancer

Phase 3 Unknown

184 enrolled

Small Cell Lung Carcinoma

NCT01593228 2017-09-19

Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial

37 enrolled

Other solid neoplasm

Solid Tumors

NCT01684878 2017-05-23

Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)

208 enrolled 19 charts

Ovarian Neoplasms

NCT01840943 2015-12-23

A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Phase 3 Terminated

32 enrolled 13 charts

Carcinoma, Ovarian Epithelial, Carcinoma, Neoplasms, Ovarian Neoplasms

NCT00390806 2014-01-20

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

472 enrolled 35 charts

Carcinoma, Non-Small-Cell Lung

NCT00043927 2013-08-21

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

760 enrolled